Pedro Machado

Active 1998–2026

234
Papers
19,442
Citations
70
h-index
167
i10-index

Citations

Citations per year for Pedro Machado1986: 1 citations1988: 3 citations2003: 2 citations2004: 1 citations2005: 3 citations2008: 2 citations2009: 2 citations2010: 6 citations2011: 35 citations2012: 27 citations2013: 31 citations2014: 34 citations2015: 40 citations2016: 52 citations2017: 81 citations2018: 129 citations2019: 504 citations2020: 870 citations2021: 1,220 citations2022: 1,014 citations2023: 621 citations2024: 1,004 citations2025: 404 citations2026: 14 citations1987: no citations, so this year is not shown1989–2002: no citations, so these years are not shown2006–2007: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,544 citing papers, 14.5% of this breakdownUnited Kingdom: 1,014 citing papers, 9.5% of this breakdownGermany: 751 citing papers, 7.1% of this breakdownFrance: 620 citing papers, 5.8% of this breakdownItaly: 593 citing papers, 5.6% of this breakdownNetherlands: 502 citing papers, 4.7% of this breakdownCanada: 458 citing papers, 4.3% of this breakdownChina: 455 citing papers, 4.3% of this breakdownSpain: 432 citing papers, 4.1% of this breakdownSwitzerland: 312 citing papers, 2.9% of this breakdownBelgium: 239 citing papers, 2.2% of this breakdownAustralia: 236 citing papers, 2.2% of this breakdown
0%14.5%Other 32.8%

Fields

  • Medicine65.8%
  • Biochemistry, Genetics and Molecular Biology15%
  • Neuroscience10.3%
  • Immunology and Microbiology2.7%
  • Computer Science2.1%
  • Engineering1.6%
  • Other2.5%

Topics

  • Spondyloarthritis Studies and Treatments9.2%
  • Rheumatoid Arthritis Research and Therapies8.7%
  • COVID-19 Clinical Research Studies3.7%
  • SARS-CoV-2 and COVID-19 Research3.1%
  • Psoriasis: Treatment and Pathogenesis3%
  • Neuroinflammation and Neurodegeneration Mechanisms3%
  • Other69.3%

Coauthors

All papers

Open in search
  1. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sizheng Steven Zhao, Nelly Ziadé, Désirée van der Heijde - Annals of the Rheumatic Diseases 2022 cited by 929

  2. Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction

    Authors: , , , , , , , , , , , - Nature Communications 2018 cited by 801

  3. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher T. Ritchlin, Martín Rudwaleit, Adrian Tanew, Bing Thio, Douglas J. Veale, Kurt de Vlam, Désirée van der Heijde - Annals of the Rheumatic Diseases 2017 cited by 676

  4. 2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2017 cited by 1,563

  5. Studying the Fate of Tumor Extracellular Vesicles at High Spatiotemporal Resolution Using the Zebrafish Embryo

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Developmental Cell 2019 cited by 236

  6. Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores

    Authors: , , , , , , - Annals of the Rheumatic Diseases 2010 cited by 797

  7. MRI lesions in the sacroiliac joints of patients with spondyloarthritis: an update of definitions and validation by the ASAS MRI working group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2019 cited by 304

  8. MRI biomarker assessment of neuromuscular disease progression: a prospective observational cohort study

    Authors: , , , , , , , - The Lancet Neurology 2015 cited by 341

  9. International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mazen M. Dimachkie, Erik Ensrud, Floranne C. Ernste, D. Gareth Evans, Manabu Fujimoto, Ignacio García‐De La Torre, Abraham García-Kutzbach, Zoltán Griger, Latika Gupta, Marie Hudson, Florenzo Iannone, David Isenberg, Joseph L. Jorizzo, Helen Kurtz, Masataka Kuwana, Vidya Limaye, Ingrid E. Lundberg, Andrew L. Mammen, H. Mann, Frank Mastaglia, Lorna McWilliams, Christopher A. Mecoli, Federica Meloni, Frederick W. Miller, Siamak Moghadam‐Kia, Sergey Moiseev, Yoshinao Muro, Melinda Nagy‐Vincze, Clive Nayler, Merrilee Needham, Ichizo Nishino, Chester V. Oddis, Julie J. Paik, Joost Raaphorst, Lisa G. Rider, Jorge Rojas‐Serrano, Lesley Ann Saketkoo, Adam Schiffenbauer, Samuel Katsuyuki Shinjo, Vineeta Shobha, Yeong‐Wook Song, Tania Tillett, Yves Troyanov, Anneke J. van der Kooi, Mónica Vázquez-Del Mercado, Jiří Vencovský, Qian Wang, Steven R. Ytterberg, Rohit Aggarwal - Nature Reviews Rheumatology 2023 cited by 139

  10. Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2023 cited by 104

  11. Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Zara Izadi, Lindsay Jacobsohn, Patricia Katz, Lianne Kearsley‐Fleet, Philip C. Robinson, Jinoos Yazdany, Pedro Machado - Annals of the Rheumatic Diseases 2021 cited by 691

  12. The ASAS-OMERACT core domain set for axial spondyloarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Seminars in Arthritis and Rheumatism 2021 cited by 101

  13. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations

    Authors: , , , , , , , , , - Annals of the Rheumatic Diseases 2014 cited by 292

  14. Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states

    Authors: , , - Annals of the Rheumatic Diseases 2018 cited by 243

  15. British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Charalampia Papadopoulou, Neil A. Martin, Liza McCann, Hector Chinoy, for the British Society for Rheumatology Standards, Audit and Guidelines Working Group - Lara D. Veeken 2022 cited by 140

  16. Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2017 cited by 137

  17. A systematic review and meta-analysis to inform cancer screening guidelines in idiopathic inflammatory myopathies

    Authors: , , , , , , , , , , , , , , , , , , - Lara D. Veeken 2021 cited by 141

  18. Update on outcome assessment in myositis

    Authors: , , , , , , - Nature Reviews Rheumatology 2018 cited by 211

  19. Instrument selection for the ASAS core outcome set for axial spondyloarthritis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 75

  20. Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - RMD Open 2021 cited by 138

  21. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Aziz Shaibani, Kumaraswamy Sivakumar, Namita Goyal, Madoka Mori‐Yoshimura, Satoshi Yamashita, Naoki Suzuki, Masahisa Katsuno, Kenya Murata, Hiroyuki Nodera, Ichizo Nishino, Carla D Romano, Valerie Williams, John Vissing, Lixin Zhang Auberson, Min Wu, Ana de Vera, Dimitris A. Papanicolaou, Anthony A. Amato - The Lancet Neurology 2019 cited by 133

  22. MRI lesions of the spine in patients with axial spondyloarthritis: an update of lesion definitions and validation by the ASAS MRI working group

    Authors: , , , , , , , , , , , , , - Annals of the Rheumatic Diseases 2022 cited by 92

  23. Pre-assembled Nuclear Pores Insert into the Nuclear Envelope during Early Development

    Authors: , , , , , , , , , , , , - Cell 2016 cited by 129

  24. COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Holt, Jacob Roelofs, Fadi Alkufri, David J. Allen, S Shields, Stephen Murphy, Harri Sivasathiaseelan, Richard Sylvester, Abdul Jabbar Omar Alsaleh, Rhys Roberts, Kannan Nithi, Lahiru Handdunnethi, Kate Wannop, Amit Batla, Anna Sadnicka, Jananee Sivaganasundaram, Tatyana Yermakova, Ravi Dasari, Graziella Quattrocchi, Harriet A. Ball, Rebecca Cooper, Daniel Whittam, Mohanned Mustafa, Gabriel Yiin, Shayan Ashjaei, Andrew J. Westwood, Michelle D'Souza, Eng Chuan Foo, Shwe Zin Tun, Khine Khine Lwin, Gorande Kanabar - Brain 2022 cited by 100